Magazine
Psychedelic Video Museum Celebrates Virtual Launch
Contributors to the Daily Psychedelic Video platform gather on Zoom to bless the opening of the Psychedelic Video Museum: a collection of ten years’ worth of their shared visions.
Latest
Videos
ATAI Life Science founder, Christian Angermayer, talks about his psilocybin mushroom use
Christian Angermayer’s story flip flops, depending on where you hear him tell it. Though, he always points out that it was somewhere “legal” and, most importantly, not because of any struggle with depression.
Magazine
Indie Film ‘Debbie and Doug Drop Acid in the Desert’ is a Visual and Emotional Trip
‘Debbie and Doug Drop Acid in the Desert’ director, Scott Brown, talks mind-altering drugs, creating psychedelic visual effects, and dealing with depression.
Podcasts
#13 – Dear Psychedelic Researchers
On the one hand, psychedelics hold promise for personal healing and transformative individual change, and when psychedelics are eventually accepted by mainstream medicine, they will likely impact mental health outcomes for the better. But the broken systems highlighted by the coronavirus pandemic of
Magazine
How psychedelic clinical trials are being affected by coronavirus
Almost all clinical psychedelic drug research is being affected in some way or another by COVID-19. But, response measures vary from one organization to the next.
Magazine
Amidst Pandemic, Psychedelic Investor Christian Angermayer Can’t Imagine Life Beyond Capitalism
As the coronavirus pandemic rages on, Christian Angermayer, the world’s largest psychedelic pharmaceutical investor and founder of ATAI Life Sciences, calls to sacrifice public health for the sake of “the economy.”
Magazine
“Flattening The Curve is Complete BS”: Pandemic Advice From Psychedelic Investor Christian Angermayer
In response to the coronavirus pandemic, Christian Angermayer—the world’s largest psychedelic pharmaceutical investor and founder of ATAI Life Sciences—dismisses medical experts in his desperation to reboot the economy.
Magazine
Dear Psychedelic Researchers
The coronavirus has made it clear that psychedelic medicalization will not revolutionize mental healthcare without systemic socioeconomic change.
Podcasts
#12 – Capitalism can’t save us from coronavirus. Neither can psychedelics.
In the midst of increasing global engagement with the fallout of the novel coronavirus, we examine some responses to the pandemic within the “psychedelic community.” Recognizing that the US has a longstanding history of privatizing profits while socializing costs, we also discuss the normalization o
Magazine
Ayahuasca Healings’ Trinity de Guzman calls coronavirus “a necessary purge”
“The Corona Virus is a necessary purge of what is no longer in resonance,” Trinity de Guzman wrote in a recent email to his followers.
Magazine
Native American Churches Request that Peyote Not Be Included in Decriminalization Initiatives
A long-fought battle for access to peyote, and a dwindling population in the United States has led Native American Church members and peyote conservationists to request that peyote be left out of decriminalization efforts.
Podcasts
#11 + Alan Piper: Strange Nazis
Alan Piper is a maverick historian of ideas with a penchant for unique, deep dives into rich veins of psychedelia. Piper’s 2015 monograph, Strange Drugs Make for Bedfellows: Ernst Jünger, Albert Hofmann, and the Politics of Psychedelics was foundational for the critique explored in Brian Pace’s cont